Filing Details

Accession Number:
0000200406-12-000007
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-01-19 18:12:19
Reporting Period:
2011-06-17
Filing Date:
2012-01-19
Accepted Time:
2012-01-19 18:12:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
200406 Johnson & Johnson JNJ Pharmaceutical Preparations (2834) 221024240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189000 C Russell Deyo Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick NJ 08933
Vp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-12-14 877 $0.00 147,903 No 5 G Direct
Common Stock Disposition 2011-12-22 407 $0.00 147,496 No 5 G Direct
Common Stock Acquisiton 2012-01-17 2,524 $0.00 150,020 No 4 A Direct
Common Stock Acquisiton 2011-12-31 77 $0.00 7,233 No 5 J Indirect Johnson & Johnson Stock Fund under the 401(k) Savings Plan
Common Stock Disposition 2011-06-17 300 $66.27 3,108 No 4 S Indirect By Son
Common Stock Disposition 2011-06-22 50 $66.41 3,058 No 4 S Indirect By Son
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 5 G Direct
No 4 A Direct
No 5 J Indirect Johnson & Johnson Stock Fund under the 401(k) Savings Plan
No 4 S Indirect By Son
No 4 S Indirect By Son
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,703 Indirect ESOP under the 401(k) Savings Plan
Common Stock 10,771 Indirect By Wife
Common Stock 2,634 Indirect By Daughter
Footnotes
  1. Gift.
  2. Awarded under Issuer's Executive Incentive Plan.
  3. Shares acquired in the Johnson & Johnson Stock Fund under the 401(k) Savings Plan as of Plan's most recent reporting date (12/31/2011).
  4. Shares held by ESOP under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (12/31/2011).
  5. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  6. Adjusted to reflect the addition of 75 shares acquired through dividend reinvestment.